Human T cell lymphotropic viruses (HTLV-I/II) in South America: should it be a public health concern?

Journal of biomedical science

Volumn 9, Issue 6, 2002, Pages 587-595

  Carneiro Proietti, Anna Bárbara F ^a,b   Catalan Soares, Bernadette ^a   Proietti, Fernando Augusto ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FUNDAÇÃO HEMOMINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE TRANSMISSION; ETHNOLOGY; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MALE; PUBLIC HEALTH; REVIEW; SOUTH AMERICA; TOPOGRAPHY;

FEMALE; HTLV-I INFECTIONS; HTLV-II INFECTIONS; HUMANS; MALE; PUBLIC HEALTH; SOUTH AMERICA; TOPOGRAPHY, MEDICAL;

EID: 1842869339     PISSN: 10217770     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02254986     Document Type: Review

References (81)

1. Andrade CA, Lima-Martins MVC, Costa JO, Ribeiro DA, Andrade AMC, Gonçalves RC, Santos JC, Soares ES, Carneiro-Proietti ABF. Soroprevalência do HIV-I/2, HTLV-I/II e hepatites B e C em parturientes da Maternidade Odete Valadares, Belo Horizonte, Minas Gerais. Rev Bras PatoI Trop 28:41-48; 1999.
2. Andrade-Filho AS, Brites C, et al. Human Tcell leukaemia/lymphoma virus type I and type II as a common etiology of myelopathies in Bahia, Brazil. Braz J Med Biol Res 29:757-761;1996.
3. Andrade-Serpa M J, Toswill J, Schor D, Linhares D, Dobbin J, Pereira MS. Seroepidemiologic survey for antibodies to human retroviruses in human and non-human primates in Brazil. Int J Cancer 44:389-393;1989.
4. Arafijo AQC, Leite ACCB, Durra S, et at. Progression or neurological disability in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP). J Neurol Sci 129:147-151;1995.
5. Biglione M, Vidan O, Mahiieux R, et al. Seroepidemiological and molecular studies of human T cell lymphotropic virus type II, subtype b, in isolated groups of Mataco and Toba Indians of northern Argentina. AIDS Res Hum Retroviruses 15:407-417;1999.
6. Bittencourt AI. Vertical transmission of HTLV-ItII: A review. Rev Inst Med Trop Sao Paulo 40:245-251; 1998.
7. Bouzas MB, Picchio G, Muchinik G, et al. HTLV-I in Argentina. J. Acquir Imune Defic Syndr 3:741-742; 1990.
8. Bouzas MB, Muchinik G, Zapiola I, et al. HTLV-I/II in Argentina. IV Conference on Retrovirology HTLV (abstract THP5). Montego Bay, Jamaica, 1991.
9. Bouzas MB, Zapiola I, Quirvelas S, et al. HTLV type I and II infection among Indians and natives from Argentina. AIDS Res Hum Retrovirnses 10:1567-1571; 1994.
10. Brites C, Harrington W Jr, Pedroso C, Martins Netto E, Badaro R. Epidemiological characteristics of HTLV-I and II co-infection in Brazil-Jan subjects infected by HIV-I. Braz J Infect Dis 1:42-47;1997.
11. Cameiro-Proietti ABF, Lima-Martins MVC, et al. Presence of human immunodeficiency virus (human immunodeficiency virus) and T-lymphotropic virus type I and type II (HTLV I/II) in a hemophiliac population in Belo Horizonte, Brazil, and correlation with additional serological results. Haemophilia 4:47-50; 1998.
12. Cartier L, Tajima K, Araya F, et al. Preliminary study of HTLV-t seroprevalence in Chilean Indian population. Rev Med Chil 121:241-246; 1993.
13. Cartier L, Prina L. Primary polymyositis associated to HTLV-I. Rev Med Chil 124:461-464; 1996.
14. Castro-Costa CM, Salgueiro MR, Carton H, Vale OC, Arrnda AM. Tropical spastic paraparesis in northeastern Brazil. Arq Neuropsiquiatr 47:134-138; 1989.
15. Castro-Costa CM, Carton H, Goubau P, de Figueiredo EG, Giffoni SD. Tropical spastic paraparesis in the tropics and Brazil. A historical analysis. Arq Neuropsiquiatr 52:106-109; 1994.
16. Castro-Costa CM. A preliminary analysis of an experimental long-term study of motor behavior and clinical aspects of Wistar rats inoculated with blood from HTLV-I positive TSP patients from Cearfá (northeastern Brazil). In: Zaninovie V ed.: TLV, Truths and Questions. Call, Fnndación MAR, 89-95; 1996.
17. Cavatcanti M, Ferreira-Jtinio O, Puccioni M, et al. HTLV-I associated neurologic manifestation in four generations of a Brazilian family. J Acquir Immune Defic Syndr 6:213-217; 1993.
18. Cevallos R, Geffray L, Guillevin L, et al. Primitive Sjögren's syndrome in France and Ecuador. Possible involvement of HTLV-t. Bull Soc Pathol Exot 86:439-441;1993.
19. Cortes E, Detels R, Aboufalia D, et at. HIV-1, HIV-2 and HTLV-I infection in high risk groups in Brazil. N Engl J Med 320:953-958; 1989.
20. Costa CMC, Vale OC, Gouban P, Desmyter J, Carton H. Human T-cell leukaemia/lymphoma virus type I and tropical spastic paraparesis in Fortaleza (northeastern Brazil). J Trop Geogr Neurol 1:45;1991.
21. Dipierri JE, Tajima K, Cartier Robirosa L, Sonoda S. A semepidemiological survey of HTLV-I/II carriers in the Puna Jujena. Medicina (B Aires) 59:712-720; 1999.
22. Dourado I, Andrade T, Montes JC, Azevedo C, Gallo D, Galvão-Castro B. Human retrovirus in a Brasilian city with a population predominantly of African origin: Evidences for high prevalence of human T-cell Leukaemia/lymphoma virus type I and human Immunodeficiency virus type I among intravenous drug users (IDU). Estudo multicêntrico - Projeto Brasil, 1997.
23. Duenas-Bajaras E, Bernal JE, Vaught DR, et al. Human retro viruses in Amerindians of Colombia: High prevalence of human T cell lymphotropic virus type II among the Tunebo Indians. Am J Tropl Med Hyg 49:657-663; 1993.
24. Etzel A, Shibata GY, Rozman M, Jorge ML, Damas CD, Segurado AA. HTLV-I and HTLV-2 infections in HIV-1 infected individuals from Santos, Brazil: Seroprevalence and risk factors. J Acquir Immune Defic Syndr 26: 185-190;2001.
25. Farias-de-Carvalho SM, Pombo-de-Oliveira MS, Thuler LC, Rios M, Coelho EM, Catovsky D, et at. Human T-cell leukaemia/lymphoma virus type I infections in hematologic disorder patients, cancer patients, and healthy individuals from Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr Hum Retrovirol 15:238-242;1997.
26. Ferreira Oc, Vaz RS, Carvalho MB, Guerra C, Fabron AL, Hamerschlak N, et al. Human Tlymphotropic virus type I and type II infections and correlation with risk factors in blood donors from São Paulo, Brasil. Transfusion 35: 258-263;1995.
27. Ferrer JF, Pinodel N, Esteban E, et al. High rate of infection with the human T-leukaemia retrovirns type II in four Indian populations of Argentina. Virology 197:576-584; 1993.
28. Fujiyoshi T, Li HC, Lou H, Yashiki S, et al. Characteristic distribution of HTLV-I and HTLV-II carriers among native ethnic groups in South America. AIDS Res Hum Retmviruses 15:1235-1239;1999.
29. Galvão-Castro B, Distribution of human % lymphotropic virus type I among blood-donors: A nationwide Brasilian study. Transfusion 37: 242-243;1997.
30. Gasbbai AA, Bordin JO, Vieira-Filho JBP, Kuroda A, et al. Selectivity of human T-lymphotropic virus type-I (HTLV-I) and HTLV-II infection among different populations in Brazil. Am J Trop Med Hyg 49:664-671;1993.
31. Gomes I, Melo A, Proietti FA, et al. Human T lymphotropic virus tipe I (I-ITLV-I) infection in neurological patients in Salvador, Bahia, Brazil. J Neurol Sci 165:84-89;1999.
32. Gotuzzo E, Sáinchez J, Escamilla J, et al. Human T-cell lymphotropic virus type I infection among female sex workers in Peru. J Infect Dis 169:54-59;1994.
33. Guimarães ML, Bastos Fi, Telles PR, et al. Retrovirus infections in a sample of injecting drug users in Rio de Janeiro City, Brazil: Prevalence of HIV-t subtypes and co-infection with HTLV-I/II. J Clin Virol 21:143-151;2001.
34. Inostroza J, Diaz P, Saunier C. Prevalence of antibodies to HTLV-I in South American Indians (Mepuches) from Chile. Scand J Infect Dis 23:507-508; 1991.
35. Ishak R, Harrington WJ, Azevedo VN, Eiraku N, et al. Identification of human T cell lymphotropic virus type IIa infection in the Kayapo, an indigenous population of Brazil. AIDS Res Human Retroviruses 11:813-821;1995.
36. Ishak R, Vallinoto AC, Azevedo VN, Lewis M, et al. Molecular evidence of mother-to-child transmission of HTLV-IIc in the Kararao Village (Kayapo) in the Amazon Region of Brazil. Rev Soc Bras Med Trop 34:519-525;2001.
37. Kajiyama W, Kashiwagi S, Ikematsu H, et al. Intrafamilial transmission of adutt T-cell leukemia virus. J Infect Dis 154:851-857;1986.
38. Kitagawa T, Fujishita M, Taguchi I, et al. Antibodies to HTLV-I in Japanese immigrants to Brazil. JAMA 256:2342; 1986.
39. Lal RB, Povoa M, Lal AA. Seroprevalence of human T-cell leukaemia/lymphoma virus type II in Pragaminos, States of Para, Brazil. J AIDS 5:634-635;1992.
40. Leon-Ponte M, Echeverria de Perez G, Bianco N, et al. Endemic infection with HTLV-IIB in Venezuelan Indians: Molecular characterization. J Acquir Immune Defic Syndr Hum Retrovirol 5:458-464; 1998.
41. Leon-Ponte M, Noya O, Bianco N, et al. Highly endemic human T lymphotropic virus type II (HTLV-II) infection in a Venezuelan Guahibo Amerindian group. J Acquir Immune Defic Syndr Hum Retrovirol 3:281-286; 1996.
42. Lessa I, Moraes D, Moura L, Melo A. HTLV-I and myelopathy in Salvador (Northeastern Brazil). Arq Neuropsiquiatr 51:44-451; 1993.
43. Lorenzetti LS, Menna-Barreto M, Schoeler M, Chichoski L, Antonini E, Staub H. High prevalence &human T-cell leukaemia/lymphoma virus type I infection among patients with rheumatoid arthritis living in Porto Alegre, Brazil. J Acquir Immune Defic Syndr Hum Retrovirol 20:P097; 1999.
44. Maloney EM, Biggar RJ, Neet JV, Taylor ME, Hahn BH, Shaw GM, Blattner WM. Endemic Human T-ceU lymphotropic virus type II infection among isolated Brazilian Ameridians. J Infect Dis 166:100-107; 1992.
45. Maloney EM, Ramirez HC, Levin A, Blattner WA. A survey of the human T-cell lymphotropic virus type I (HTLV-I) in southern Colombia. Int J Cancer 44:419-423; 1989.
46. Martins-Castro LH, Chaves CJ, Callegaro D, et al. HTLV-I associated myelopathy in Brazil; a preliminary report. Arq Neuropsiqiatr 47:501-502;1989.
47. Medeot S, Nates S, Recalde A, et al. Prevalence of antibody to human T cell lymphotropic virus types 1/2 among aboriginal groups inhabiting northern Argentina and the Amazon region of Peru. Am J Trop Meal Hyg 60:623-629; 1999.
48. Meireles A, Moreira ED Jr, Moreno-Carvalho AO, Badaró R, Melo A. Human T-cell leukaemia/lymphoma virus type I associated myelopathy in Salvador (northeastern Brazil). Arq Neuropsiquiatr 50:189-190; 1992.
49. Menna-Barreto M, Doval A, Rabolini G, Blanchini O. HTLV-I associated myelopathy in Porto Alegre (southern Brazil). Arq Neuropsiquiatr 53:771-776;1995.
50. Merino F, Robert-Guroff M, Clark J, et al. Natural antibodies to human T-cell teukemia/lymphoma virus in healthy Venezuelan population. Int J Cancer 40:260-270; 1984.
51. Miura T, Yamashita M, Zaninovic V, et al. Molecular phylogeny of human T-cell leukemia virus type I and II of Amerindians in Colombia and Chile. J Mol Evol 44(suppl 1):S76-S82; 1997.
52. Moreira ED, Ribeiro TF, Swanson P, Filho CS, Meto A, Brites C, Badaró R, Toedter G, Lee H, ttarrington Jr. W. Seroepidemiology of human T-cell lymphotropic virus type I/II in Northeastern Brazil. J Acquit Immun Defic Syndr Hum Retrovirol 6:959-963;1993.
53. Mori N, Gill OS, Mougdil T, Murakami S, Eto S, Prager D. Interleukin gene expression in adult T ceil leukemia. Blood 88:1035-1045; 1996.
54. Muchinik G, Bouzas MB, Zapiola I. HTLV-I and HTLV-II infection in Uruguay. J Aequir Immun Defic Syndr Hum Retrovirol 5:743-747; 1992.
55. Murphy EL, Blattner WA. Human T-cell leukaemia/ lymphoma virus type I associated leukemia: A model for chronic retroviral diseases. Ann Neurology 23 (suppl): S174-S180;1987.
56. Murphy EL, Glynn AS, Fridey J, et al. Increased incidence of infectious diseases during prospective follow-up of human T-lymphotropic virus type II and Mnfected blood donors. Arch Interu Med 159:1485-1491; 1999.
57. Nakauchi CM, Linhares AC, Maruyama K, et al. Prevalence of human T-cell leukemia virus (human T-cell leukaemia/tymphoma virus) antibody among populations living in the Amazon region of Brazil (preliminary report). Mem Inst Oswaldo Cruz 85:29-33; 1990.
58. Nakauchi CM, Muruyama K, Kanzaki LI, et al. Prevalence of HTLV-I antibody among two distinct ethnic groups inhabiting the Amazon region of Brazil. Rev Inst Med Trop Sao Paulo 34: 323-328; 1992.
59. Nogueira CM, Cavalcanti M, Schechter M, Ferreira OC Jr. Human T lymphotropic virus type I and II infections in healthy blood donors from Rio de Janeiro, Brasil. Vox Sang 70:47-48; 1996.
60. Novoa P, Granato GFH, Barnzzi RG, Hall WW. Evidence for and the rate of motherto-child transmission of human T-cell leukaemia/ lymphoma virus type II among Kaiapo Indians, Brazil. Eighth International Conference on Human retrovirology: HTLV, Rio de Janeiro, Brazil, 1997.
61. Oliveira MSP, Hamerschlak N, Chiattone C, Loureiro P. Human T-cell leukaemia/lymphoma virus type I infection and adult T-cell leukemia in Brazil: An overview. São Paulo Med J 114:1177-1185; 1996.
62. Pancake BA, Zucker FD, Marmot M, et al. Determination of true prevalence of infection with the human T-cell Iymphotropic viruses (HTLV-I/II) may require a combination ofbiomolecular and serological analyses. Proc Assoc Am Physicians 108:444-448;1996.
63. Pino N, Peralta LM, Pampuro S, et al. HTLVI/ II seroprevalence and co-infection with other pathogens in blood donors in Buenos Aires. J Acquir Immune Defic Syndr Hum Retrovirol 7:206-207;1994.
64. Pombo-de-Oliveira MS. An update of human T-cell leukaemia/lymphoma virus type I and type II infections studies in Brazil. In: Eighth International Conference on Human Retrovirology: HTLV, Rio de Janeiro, Brazil, 1997.
65. Pombo-de-Oliveira MS, Matutes E, Fanadas LC, Schultz TF, Calabro ML, Nucci M, et al. Adult T-cell leukaemia/lymphoma in Brazil and its relation to HTLV-I. Lancet 336:987; 1990.
66. Pombo-de-Oliveira MS, Matutes E, Schultz T, et al. T-cell malignancies in Brazil. Clinicpathological and molecular studies of HTLV-I positive and negative cases. Int J Cancer 60: 82-87;1995.
67. Proietti FA, Lima-Martins MVC, Passos VMA, Brener S, Carneiro-Proietti ABF. Human T-cell leukaemia/lyrnphoma virus type I and type II seropositivity among eligible blood donors fi'om Minas Gerais State, Brazil. Vox Sang 67:77; 1994.
68. Proietti F, Caiaffa W, Carneiro-Proietti AB, et al. Seroprevalence correlates of HTLV-I/II among injecting drug users attending Brazilian syringe exchange programs (SEPs) - the AjUDE - Brazil Project. AIDS Res Hum Retroviruses 17:540;2001.
69. Saraiva JCP, Saraiva ASL, Couroucé FCAM. Detecção de anticorpos anti-ItTLV-I em doadores de sangue no Belém do Pará. XlI Congresso Nacional do Colégio Brasileiro de Hematologia, Fortaleza, 1989.
70. Sarim SG, Fang C, Williams A. Retroviral infections transmitted by blood transfusion. Yale J Biol Med 82:1100-1106;1990.
71. Segurado AAC, Sumita LM, Rozmann M, et al. HTLV-I and HTLV-II infections in inmates of São Paulo State Prison, São Paulo, Brazil. Abstract J AIDS 10:263;1995.
72. Slattery JP, Franchini G, Gessain A. Genomic evolution, patterns of global dissemination, and interspecies transmission of human and simian T-cell leukemia/lymphotropic viruses. Genome Res 9:525-540;1999.
73. Sonoda S, Li HC, Cartier L, Nunez L, Tajima K. Ancient HTLV type 1 provirus DNA of Andean mummy. AIDS Res Hum Retroviruses 16:1753-1756;2000.
74. Tajima K, Tominaga S, Suchi T, et al. Epidemiotogical analysis of the distribution of antibody to adult T-cells leukemia virus-associated antigen: Possible horizontal transmission of adult T-cell leukemia virus. Jap J Cancer Res 73:893-901;1982.
75. Tallarmin A, Vion B, Ureta-Vidal A, Dn Fou G, Marty C, Kazanji M. First seroepidemiological study and phylogenetic characterization of human T-cell lymphotropic virus type I and II infection among Amerindians in French Guyaha. J Gen Virol 80:3083-3088; 1999.
76. Trujillo L, Munoz D, Gotuzzo E, Yi A, Watts DM. Sexual practices and prevalence of HI'g, HTLV-I/II and Treponema pallidum among clandestine female sex workers in Lima, Peru. Sex Transm Dis 26:115-118;1999.
77. Vasquez P, Sanchez G, Volante C, et al. Human T-lymphotropic virus type I new risk for Chilean population. Blood 78:850; 1991.
78. Wendel NS, Luzzi JR, Russo C, Fontal RC. Avaliaggo inicial dos teste anti-HTLV-I na rotiua soroldgica de banco de sangue. Rev Soc Bras Hemat Hemot 12:34; 1990.
79. Zaninovic V, Sanzon F, Lopes F, et al. Geographic independence of HTLV-I and HTLVII foci in the Andes Highland, the Atlantic Coast, and the Orinoco of Colombia. AIDS Res Hum Retroviruses 10:97-101; 1994.
80. Zoulek G, Schatzl H, Kawabata M, et al. A seroprevalence survey of antibodies to HTLVI/ II in selected population groups in Paraguay. Scand J Infect Dis 24:397-398; 1992.
81. Zucker FD, Pancake BA, Marmot M, Legler PM. Reexamination of human T cell lymphotropic virus type I and type II (HTLV-I/II) prevalence. Proc Natl Acad Sci USA 94:6403-6407; 1997.